Northwestern University Human Resources
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
A Novel Treatment for Metastatic Melanoma
Phase 1
Terminated
- Conditions
- Metastatic Melanoma
- Interventions
- Other: Photoimmunotherapy
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 7
- Registration Number
- NCT00758797
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Not Applicable
Withdrawn
- Conditions
- Actinic Keratoses
- Interventions
- Procedure: Photodynamic Therapy (PDT)Procedure: Topical retinoid and blue-light therapy with photosensitizing agent
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2021-12-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00756288
Parkinson's Disease Isradipine Safety Study
- First Posted Date
- 2008-09-16
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 31
- Registration Number
- NCT00753636
- Locations
- 🇺🇸
710 N. Lake Shore Dr., Chicago, Illinois, United States
Temperature Control in Central Fever in the Neuro-ICU
Phase 4
Completed
- Conditions
- FeverBrain Hemorrhage
- Interventions
- Device: Gaymar Rapr-Round (external cooling blanket)
- First Posted Date
- 2008-09-12
- Last Posted Date
- 2013-05-06
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 20
- Registration Number
- NCT00751634
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
Efalizumab in the Treatment of Alopecia, Phase II
- First Posted Date
- 2008-09-04
- Last Posted Date
- 2016-06-14
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00746980
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
Not Applicable
Terminated
- Conditions
- REM Behavior DisorderParkinsonism
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-09-01
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 3
- Registration Number
- NCT00745030
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Postpartum Depression: Transdermal Estradiol Versus Sertraline
Phase 4
Terminated
- Conditions
- Postpartum Depression
- Interventions
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 85
- Registration Number
- NCT00744328
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine; Asher Center for the Study and Treatment of Depressive Disorders, Chicago, Illinois, United States
Women With Chest Pain and Normal Coronary Arteries Study
Not Applicable
Terminated
- Conditions
- Chest Pain
- Interventions
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 3
- Registration Number
- NCT00743197
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Modification of Asthma With Soy Isoflavone
Not Applicable
Completed
- Conditions
- Asthma
- Interventions
- Dietary Supplement: Soy Isoflavone
- First Posted Date
- 2008-08-26
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 20
- Registration Number
- NCT00741208
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD
Not Applicable
Withdrawn
- Conditions
- Chronic Obstructive Pulmonary DiseaseSleep Disorders
- Interventions
- Drug: salmeterol-fluticasone
- First Posted Date
- 2008-08-26
- Last Posted Date
- 2015-10-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00741767
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath